ScholarIQanswers from OpenAlex

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside

PaperCitations, authors & open-access status

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside have?

ScholarIQcitation count

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside has 88 citations in the OpenAlex counts ScholarIQ stores.

When was Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside published?

ScholarIQyear

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside has 2012 year in the ScholarIQ index.

What is the open-access status of Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

ScholarIQoa status

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside has green oa status in the ScholarIQ index.

What is the DOI of Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

ScholarIQdoi

The DOI for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is on the source record.

What is the PMID of Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

ScholarIQpmid

The PMID for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is on the source record.

What is the OpenAlex record for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

ScholarIQopenalex

The OpenAlex for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial